OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The application basis of immuno-checkpoint inhibitors combined with chemotherapy in cancer treatment
Ming-Yan Shi, Han-Ge Liu, Xiaohong Chen, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 8
Ming-Yan Shi, Han-Ge Liu, Xiaohong Chen, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 8
Showing 8 citing articles:
Recent Advancement of PD-L1 Detection Technologies and Clinical Applications in the Era of Precision Cancer Therapy
Yuanfeng Zhang, Juanjuan Wu, Chaobin Zhao, et al.
Journal of Cancer (2023) Vol. 14, Iss. 5, pp. 850-873
Open Access | Times Cited: 16
Yuanfeng Zhang, Juanjuan Wu, Chaobin Zhao, et al.
Journal of Cancer (2023) Vol. 14, Iss. 5, pp. 850-873
Open Access | Times Cited: 16
Efficacy and safety of autologous CIK cell therapy plus Toripalimab with or without chemotherapy in advanced NSCLC : A phase II study
Runbo Zhong, Tianqing Chu, Liwen Xiong, et al.
International Journal of Cancer (2025)
Closed Access
Runbo Zhong, Tianqing Chu, Liwen Xiong, et al.
International Journal of Cancer (2025)
Closed Access
FAM109B plays a tumorigenic role in low-grade gliomas and is associated with tumor-associated macrophages (TAMs)
Zhe Zhang, Yao Xiao, Siyi Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Zhe Zhang, Yao Xiao, Siyi Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Additional PD-1 inhibitor improves complete response to induction chemotherapy in locally advanced nasopharyngeal carcinoma
Yi‐Feng Yu, Guanzhong Lu, Runjie Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Yi‐Feng Yu, Guanzhong Lu, Runjie Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Efficacy and safety of camrelizumab-based comprehensive treatment for non-small cell lung cancer: a systematic review and meta-analysis
Nuerbiyamu Maimaitiyiming, Yue Li, Yun‐Feng Cao, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Nuerbiyamu Maimaitiyiming, Yue Li, Yun‐Feng Cao, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
Three years follow-up of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
Wenhao Ji, Youhua Jiang, Yuetong Li, et al.
Neoplasma (2024) Vol. 71, Iss. 01, pp. 88-97
Open Access
Wenhao Ji, Youhua Jiang, Yuetong Li, et al.
Neoplasma (2024) Vol. 71, Iss. 01, pp. 88-97
Open Access
Immunoadjuvants in Cancer Immunotherapy
Mamta N. Talati, Neeraj Kumar Chouhan, Mani Sharma, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 311-350
Closed Access
Mamta N. Talati, Neeraj Kumar Chouhan, Mani Sharma, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 311-350
Closed Access
Immunogenic cell death: A new strategy to enhancing cancer immunotherapy
Lei Dou, Fang Yu, Huiyuan Yang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Lei Dou, Fang Yu, Huiyuan Yang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
